{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:52:56Z","timestamp":1790812376194,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hair and Skin Research Grant 2022\u201d held by L\u2019oreal, Indonesian Society of Dermatology and Venereology (PERDOSKI), and Universitas Indonesia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04216-9","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:05:19Z","timestamp":1744358719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1% finasteride \u2212\u20095% Minoxidil in male androgenetic alopecia"],"prefix":"10.1007","volume":"317","author":[{"given":"Farah Faulin","family":"Lubis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Legiawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Saulina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti R.F.","family":"Saldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"4216_CR1","unstructured":"Kang S, Amagai M, Bruckner AL et al (eds) (2019) Fitzpatricks Dermatol.;9e"},{"key":"4216_CR2","doi-asserted-by":"crossref","unstructured":"Legiawati L, Suseno LS, Sitohang IBS, Pratama AI (2022) Hair disorder in dr. Cipto Mangunkusumo cosmetic dermatology and venereology outpatient clinic of Jakarta, Indonesia: A socio-demographic and clinical evaluation. Dermatol Rep.;14","DOI":"10.4081\/dr.2022.9341"},{"key":"4216_CR3","doi-asserted-by":"crossref","unstructured":"Chhetri D, Huang X (2021) Management of androgenetic alopecia: a review. Int J Res Dermatol.;7","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20210013"},{"key":"4216_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/der2.58","volume":"2","author":"RS Dhurat","year":"2021","unstructured":"Dhurat RS, Daruwalla SB (2021) Androgenetic alopecia: update on etiology. Dermatol Rev 2:115\u2013121","journal-title":"Dermatol Rev"},{"key":"4216_CR5","first-page":"457","volume":"17","author":"SW Lee","year":"2018","unstructured":"Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA (2018) A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatol 17:457\u2013463","journal-title":"J Drugs Dermatol"},{"key":"4216_CR6","doi-asserted-by":"crossref","unstructured":"Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A (2019) The Role of Vitamins and Minerals in Hair Loss: A Review","DOI":"10.1007\/s13555-018-0278-6"},{"key":"4216_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","volume":"57","author":"F Lolli","year":"2017","unstructured":"Lolli F, Pallotti F, Rossi A et al (2017) Androgenetic alopecia: a review. Endocrine 57:9\u201317","journal-title":"Endocrine"},{"key":"4216_CR8","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s40265-016-0629-5","volume":"76","author":"Y Kelly","year":"2016","unstructured":"Kelly Y, Blanco A, Tosti A (2016) Androgenetic alopecia: an update of treatment options. Drugs 76:1349\u20131364","journal-title":"Drugs"},{"key":"4216_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/09546634.2013.813011","volume":"25","author":"AK Gupta","year":"2014","unstructured":"Gupta AK, Charrette A (2014) The efficacy and safety of 5\u03b1-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J Dermatol Treat 25:156\u2013161","journal-title":"J Dermatol Treat"},{"key":"4216_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/09546634.2020.1782324","volume":"33","author":"P Suchonwanit","year":"2022","unstructured":"Suchonwanit P, Iamsumang W, Leerunyakul K (2022) Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature. J Dermatol Treat 33:643\u2013648","journal-title":"J Dermatol Treat"},{"key":"4216_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1346-8138.2002.tb00314.x","volume":"29","author":"S Khandpur","year":"2002","unstructured":"Khandpur S, Suman M, Reddy BS (2002) Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 29:489\u2013498","journal-title":"J Dermatol"},{"key":"4216_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/dth.12246","volume":"28","author":"R Hu","year":"2015","unstructured":"Hu R, Xu F, Sheng Y et al (2015) Combined treatment with oral finasteride and topical Minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther 28:303\u2013308","journal-title":"Dermatol Ther"},{"key":"4216_CR13","doi-asserted-by":"crossref","unstructured":"Rai P, Khushwaha P, Jain N, Gupta S (2018) Comparing the therapeutic efficacy of topical Minoxidil and finasteride with topical Minoxidil and oral finasteride in androgenetic alopecia: a randomized trial. Int J Res Dermatol.;4","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20183163"},{"key":"4216_CR14","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s00266-020-01621-5","volume":"44","author":"L Chen","year":"2020","unstructured":"Chen L, Zhang J, Wang L, Wang H, Chen B (2020) The efficacy and safety of finasteride combined with topical Minoxidil for androgenetic alopecia: A systematic review and Meta-analysis. Aesthetic Plast Surg 44:962\u2013970","journal-title":"Aesthetic Plast Surg"},{"key":"4216_CR15","first-page":"1312","volume":"95","author":"C Tanglertsampan","year":"2012","unstructured":"Tanglertsampan C (2012) Efficacy and safety of 3% Minoxidil versus combined 3% Minoxidil \/ 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai 95:1312\u20131316","journal-title":"J Med Assoc Thai"},{"key":"4216_CR16","first-page":"1","volume":"6","author":"S Sheikh","year":"2015","unstructured":"Sheikh S, Ahmad A, Ali SM et al (2015) A new topical formulation of Minoxidil and finasteride improves hair growth in men with androgenetic alopecia. J Clin Exp Dermatol Res 6:1\u20136","journal-title":"J Clin Exp Dermatol Res"},{"key":"4216_CR17","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/jdv.15171","volume":"32","author":"P Suchonwanit","year":"2018","unstructured":"Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S (2018) A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% Minoxidil vs. 3% Minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol 32:2257\u20132263","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4216_CR18","doi-asserted-by":"crossref","unstructured":"Gowda A, Sushmitha K, Chandra K (2021) Comparative study of efficacy of topical Minoxidil versus topical Minoxidil with finasteride in androgenetic alopecia. Int J Res Dermatol.;7","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20211448"},{"key":"4216_CR19","unstructured":"BPOM (2020) Finasterid dan Minoxidil"},{"key":"4216_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM (1999) Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319\u2013326","journal-title":"Int J Impot Res"},{"key":"4216_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5152\/tud.2021.21185","volume":"47","author":"TB Laksita","year":"2021","unstructured":"Laksita TB, Kloping YP, Hakim L, Rizaldi F (2021) Translation validity and reliability of the Indonesian version of the 5-item international index of erectile function (IIEF-5. Turk J Urol 47:489\u2013494","journal-title":"Turk J Urol"},{"key":"4216_CR22","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/j.1743-6109.2007.00600.x","volume":"4","author":"JP Mulhall","year":"2007","unstructured":"Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K (2007) Validation of the erection hardness score. J Sex Med 4:1626\u20131634","journal-title":"J Sex Med"},{"key":"4216_CR23","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1053\/meta.2000.8625","volume":"49","author":"JE Morley","year":"2000","unstructured":"Morley JE, Charlton E, Patrick P et al (2000) Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49:1239\u20131242","journal-title":"Metabolism"},{"key":"4216_CR24","unstructured":"Silva Pinto YKAC, Pramesmara IGN (2021) Hubungan Andropause Dengan Skor IPSS Pda Pegawai Di institusi Pusat Pemerintahan Kabupaten Badung-Bali. Intisari Sains Medis.;12"},{"key":"4216_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3889\/oamjms.2022.9293","volume":"10","author":"CN Dian","year":"2022","unstructured":"Dian CN, Effendy E, Amin MM (2022) The validation of Indonesian version of patient health Questionnaire-9. Open Access Maced J Med Sci 10:193\u2013198","journal-title":"Open Access Maced J Med Sci"},{"key":"4216_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00128071-200708050-00003","volume":"8","author":"HS Shin","year":"2007","unstructured":"Shin HS, Won CH, Lee SH et al (2007) Efficacy of 5% Minoxidil versus combined 5% Minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Am J Clin Dermatol 8:285\u2013290","journal-title":"Am J Clin Dermatol"},{"key":"4216_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/ijd.IJD_526_16","volume":"64","author":"RV Vora","year":"2019","unstructured":"Vora RV, Kota R, Singhal RR, Anjaneyan G (2019) Clinical profile of androgenic alopecia and its association with cardiovascular risk factors. Indian J Dermatol 64:19\u201322","journal-title":"Indian J Dermatol"},{"key":"4216_CR28","doi-asserted-by":"crossref","unstructured":"Narasimhalu CRV (2018) A cross-sectional randomized comparative study of topical Minoxidil solution with and without finasteride in male pattern androgenetic alopecia in South Indian patients. Int J Res Dermatol.;4","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20180138"},{"key":"4216_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/CCID.S247390","volume":"13","author":"K Leerunyakul","year":"2020","unstructured":"Leerunyakul K, Suchonwanit P, Asian Hair (2020) A review of structures, properties, and distinctive disorders. Clin Cosmet Investig Dermatol 13:309\u2013318","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"4216_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/jocd.15953]","volume":"23","author":"A Rossi","year":"2024","unstructured":"Rossi A, Caro G (2024) Efficacy of the association of topical Minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial. J Cosmet Dermatol 23:502\u2013509 [DOI:. https:\/\/doi.org\/10.1111\/jocd.15953]","journal-title":"J Cosmet Dermatol"},{"key":"4216_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.5414\/CP202119","volume":"52","author":"M Caserini","year":"2014","unstructured":"Caserini M, Radicioni M, Leuratti C, Annoni O, Palmieri R (2014) A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther 52:842\u2013849","journal-title":"Int J Clin Pharmacol Ther"},{"key":"4216_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5414\/CP202467","volume":"54","author":"M Caserini","year":"2016","unstructured":"Caserini M, Radicioni M, Leuratti C et al (2016) Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. Int J Clin Pharmacol Ther 54:19\u201327","journal-title":"Int J Clin Pharmacol Ther"},{"key":"4216_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/jdv.17738","volume":"36","author":"BM Piraccini","year":"2022","unstructured":"Piraccini BM, Blume-Peytavi U, Scarci F et al (2022) Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol 36:286\u2013294","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4216_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5455\/medarh.2021.75.109-111","volume":"75","author":"E Kasumagic-Halilovic","year":"2021","unstructured":"Kasumagic-Halilovic E (2021) Trichoscopic findings in androgenetic alopecia. Med Arch 75:109\u2013111","journal-title":"Med Arch"},{"key":"4216_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00403-003-0447-y","volume":"295","author":"C Deloche","year":"2004","unstructured":"Deloche C, Lacharriere O, Misciali C et al (2004) Histological features of Peripilar signs associated with androgenetic alopecia. Arch Dermatol Res 295:422\u2013428","journal-title":"Arch Dermatol Res"},{"key":"4216_CR36","first-page":"6","volume":"4","author":"D Datta","year":"2021","unstructured":"Datta D, Saha A, Gharami RC, Das NK, Bandyopadhyay D (2021) Effectiveness of topical Minoxidil (5%) plus topical finasteride (0.1%) Fixed-Dose combination versus topical Minoxidil (5%) plus oral finasteride (1 Mg\/Day) in grade II-IV androgenetic alopecia: A randomized, double blind clinical trial. AJRDES 4:6\u201318","journal-title":"AJRDES"},{"key":"4216_CR37","doi-asserted-by":"publisher","first-page":"82074","DOI":"10.18632\/oncotarget.12617","volume":"7","author":"M Wu","year":"2016","unstructured":"Wu M, Yu Q, Li Q (2016) Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases. Oncotarget 7:82074\u201382084","journal-title":"Oncotarget"},{"key":"4216_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/jrpp.JRPP_18_23","volume":"7","author":"F Gheshlaghi","year":"2018","unstructured":"Gheshlaghi F, Zoofaghari S, Dorooshi G (2018) Unstable angina: A rare presentation of Minoxidil intoxication: A case report and literature review. J Res Pharm Pr 7:210\u2013212","journal-title":"J Res Pharm Pr"},{"key":"4216_CR39","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.2147\/DDDT.S214907","volume":"13","author":"P Suchonwanit","year":"2019","unstructured":"Suchonwanit P, Thammarucha S, Leerunyakul K (2019) Minoxidil and its use in hair disorders: a review. Drug Devel Ther 13:2777\u20132786","journal-title":"Drug Devel Ther"},{"key":"4216_CR40","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s13555-023-00919-x","volume":"13","author":"Z Shadi","year":"2023","unstructured":"Shadi Z (2023) Compliance to topical Minoxidil and reasons for discontinuation among patients with androgenetic alopecia. Dermatol Ther 13:1157\u20131169 [DOI: 10.1007\/s13555-023-00919-x]","journal-title":"Dermatol Ther"},{"key":"4216_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/14656566.2020.1721463","volume":"21","author":"K York","year":"2020","unstructured":"York K, Meah N, Bhoyrul B, Sinclair R (2020) A review of the treatment of male pattern hair loss. Expert Opin Pharmacother 21:603\u2013612","journal-title":"Expert Opin Pharmacother"},{"key":"4216_CR42","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.2147\/OPTH.S259011","volume":"15","author":"JA Katz","year":"2021","unstructured":"Katz JA, Karpecki PM, Dorca A et al (2021) Presbyopia\u2013 A review of current treatment options and emerging therapies. Clin Ophthalmol 15:2167\u20132178 [DOI: 10.2147\/OPTH.S259011]","journal-title":"Clin Ophthalmol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04216-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04216-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04216-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:05:28Z","timestamp":1744358728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04216-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4216"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04216-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study had been given ethical clearance by the Research Ethics Committee of Faculty of Medicine Universitas Indonesia (KET-374\/UN2.F1\/ETIK\/PPM.00.02\/2023) and permission from RSCM (YR.02.01\/2.6.1\/0454\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"691"}}